Related Experiment Video

Updated: May 21, 2026

A Rat Carotid Artery Pressure-Controlled Segmental Balloon Injury with Periadventitial Therapeutic Application
06:53

A Rat Carotid Artery Pressure-Controlled Segmental Balloon Injury with Periadventitial Therapeutic Application

Published on: July 9, 2020

Medical treatment of carotid endarterectomy patients requires attention

Tiina Sairanen1, Pirkka Vikatmaa, Juha-Matti Lindholm

  • 1Department of Neurology, Helsinki University Central Hospital, Finland. tiina.sairanen@hus.fi

Neurological Research
|June 27, 2012
PubMed

Insights

Patients undergoing carotid endarterectomy (CEA) receive high medication rates, exceeding past trials. However, some symptomatic patients experienced stroke events while awaiting surgery, indicating room for improved secondary prevention strategies.

Area of Science:

  • Vascular Surgery
  • Neurology
  • Cardiology

Background:

  • Prophylactic carotid endarterectomy (CEA) combined with best medical treatment (BMT) is established for stroke prevention.
  • Early BMT initiation is crucial for reducing stroke risk during potentially long CEA waiting periods.

Purpose of the Study:

  • To evaluate preoperative medical treatment in CEA patients at a single center.
  • To assess adherence of current medical treatment to national/international secondary prevention guidelines and compare with other CEA cohorts.

Main Methods:

  • Retrospective study of 135 consecutive patients undergoing CEA for symptomatic (n=100) or asymptomatic (n=35) carotid artery stenosis.
  • Data collected over a 14-month period (2007-2008) at a tertiary care center.

Main Results:

  • High medication use at surgery: 93.3% on antiplatelet therapy, 92.6% on statins, and 89.6% on antihypertensives.
  • While awaiting CEA, 10% of symptomatic patients experienced recurrent or progressive ischemic symptoms, with a median waiting time of 8.5 days.

Conclusions:

  • Carotid artery stenosis patients are high-risk, irrespective of symptom status.
  • Current medication use surpasses that in landmark CEA trials, suggesting improved adherence to BMT.
  • Despite high medication rates, opportunities exist to further optimize secondary stroke prevention in CEA patients.
Abstract

More Related Videos

Vascular Gene Transfer from Metallic Stent Surfaces Using Adenoviral Vectors Tethered through Hydrolysable Cross-linkers12:30

Vascular Gene Transfer from Metallic Stent Surfaces Using Adenoviral Vectors Tethered through Hydrolysable Cross-linkers

Published on: August 12, 2014

Related Concept Videos

Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...